Stock data
Annovis Bio, Inc. (ANVS)
Annovis Bio, Inc. (ANVS) reported revenue of US$0.00M and net income of -US$28.85M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.00M | — | -US$29.70M | -US$28.85M | — |
| 2024 | US$0.00M | — | -US$26.69M | -US$24.59M | — |
| 2023 | US$0.00M | — | -US$45.04M | -US$56.20M | — |
| 2022 | US$0.00M | — | -US$25.51M | -US$25.33M | — |
| 2021 | US$0.00M | — | -US$14.54M | -US$14.49M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$14.82M | — |
| 2026-03-31 | US$0.00M | -US$17.61M | — |
| 2025-12-31 | — | -US$9.83M | — |
| 2025-09-30 | — | -US$7.26M | — |
| 2025-06-30 | — | -US$6.22M | — |
| 2025-03-31 | US$0.00M | -US$5.54M | — |
| 2024-12-31 | — | -US$5.86M | — |
| 2024-09-30 | — | -US$12.64M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.